Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma

Related articles

1. Genomic correlations for clinical outcomes in HER2-positive advanced gastric cancers treated using trastuzumab-based therapy

   This article has 7 authors:

   1. Sun Young Lee
   2. Jaewon Hyung
   3. Hyung-Don Kim
   4. Hyungeun Lee
   5. Meesun Moon
   6. Young Soo Park
   7. Min-Hee Ryu

2. A Study on the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy in Patients with Oligometastatic Driver Gene-Negative Non-Small Cell Lung Cancer Undergoing Radiotherapy

   This article has 10 authors:

   1. Yang Liu
   2. Lingxiao Xie
   3. Jiaoyue Qu
   4. Quan Pan
   5. Zhao Yu
   6. Yin Yuan
   7. Chunyu Chang
   8. Hao Jiang
   9. Yuexin Yang
   10. Gengming Wang at

3. Periphery TH/TS ratio and TP53 mutation predict the efficacy of ICI-based therapy in advanced non-small cell lung cancer with high PD-L1 expression

   This article has 4 authors:

   1. Fang Hao
   2. Qing Ma
   3. Linlin Zhang
   4. Diansheng Zhong